s6y
Company name or ticker
Search
Taysha Gene Therapies, Inc.
4
Nagendran Sukumar: Statement of changes in beneficial ownership of securities
Filed
Monday, April 13, 2026
Period
Apr 10, 2026
Accession number
0001665124-26-000011
Documents
form4-04132026_080454.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header